创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

高级检索
侯静静, 龚慧, 赵翊畅, 徐萍, 张毕奎, 颜苗. 新型冠状病毒肺炎治疗中的药物不良反应与防治[J]. 药学进展, 2020, 44(2): 153-158.
引用本文: 侯静静, 龚慧, 赵翊畅, 徐萍, 张毕奎, 颜苗. 新型冠状病毒肺炎治疗中的药物不良反应与防治[J]. 药学进展, 2020, 44(2): 153-158.
shu
HOU Jingjing, GONG Hui, ZHAO Yichang, XU Ping, ZHANG Bikui, YAN Miao. Prevention and Treatment of Adverse Drug Reactions in COVID-19[J]. Progress in Pharmaceutical Sciences, 2020, 44(2): 153-158.
Citation: HOU Jingjing, GONG Hui, ZHAO Yichang, XU Ping, ZHANG Bikui, YAN Miao. Prevention and Treatment of Adverse Drug Reactions in COVID-19[J]. Progress in Pharmaceutical Sciences, 2020, 44(2): 153-158.
shu

新型冠状病毒肺炎治疗中的药物不良反应与防治

Prevention and Treatment of Adverse Drug Reactions in COVID-19

    摘要
  • 摘要: 围绕《新型冠状病毒感染的肺炎诊疗方案（试行第六版）》中的治疗试用药物，包括抗病毒药物、糖皮质激素和中药，从各药的作用机制、药物相互作用、药物不良反应等方面，综述新型冠状病毒肺炎（COVID-19）治疗中可能出现的不良反应及防治策略，为临床治疗方案的合理选择提供参考。

     

    Abstract: Based on the medication regimens recommended by Diagnosis and Treatment Scheme for COVID-19 (Trial Version 6.0), including antiviral drugs, corticosteroids and traditional Chinese medicines, this article reviews the possible adverse reactions and their prevention and treatment strategy during the treatment of COVID-19 in terms of the mechanisms of action, drug interactions and adverse drug reactions, aiming to provide reference for the selection of reasonable therapeutic regimens.

     

    • HTML全文
    • 参考文献(28)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回